fluoxetine has been researched along with Cancer of Liver in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Arteta, B; Curzytek, K; Grygier, B; Kubera, M; Maes, M; Malicki, S | 1 |
| Chiang, IT; Hsu, FT; Hsu, LC; Tu, HF; Yueh, PF | 1 |
| Chen, KC; Hsieh, CL; Maner, RS; Tian, YS; Zulkefli, ND | 1 |
| Chen, CH; Chen, WT; Hsu, FT; Hsu, LC; Lin, SS; Liu, YC | 1 |
| Kang, HS; Kim, GB; Kim, JS; Kim, SJ; Lee, SJ; Mun, AR | 1 |
| Chen, HZ; Liu, YM; Ma, J; Peng, L; Qi, H; Wang, H; Yang, L | 1 |
| Cai, W; Khaoustov, VI; Le, W; Pan, T; Xie, Q; Yoffe, B | 1 |
7 other study(ies) available for fluoxetine and Cancer of Liver
| Article | Year |
|---|---|
Stimulatory effect of fluoxetine and desipramine, but not mirtazapine on C26 colon carcinoma hepatic metastases formation: association with cytokines.
Topics: Animals; Antidepressive Agents; Carcinoma; Colonic Neoplasms; Cytokines; Desipramine; Fluoxetine; Liver Neoplasms; Male; Mice; Mirtazapine | 2023 |
Beneficial effect of fluoxetine on anti-tumor progression on hepatocellular carcinoma and non-small cell lung cancer bearing animal model.
Topics: Adjuvants, Pharmaceutic; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Fluoxetine; Humans; Liver; Liver Neoplasms; Lung; Lung Neoplasms; Male; Mice; Mice, Nude; Signal Transduction | 2020 |
Evaluation of the Inhibitory Effects of Genipin on the Fluoxetine-Induced Invasive and Metastatic Model in Human HepG2 Cells.
Topics: Carcinoma, Hepatocellular; Fluoxetine; Hep G2 Cells; Humans; Iridoids; Liver Neoplasms; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Transcription Factor AP-1 | 2018 |
Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Fluoxetine; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Models, Biological; NF-kappa B; Signal Transduction | 2019 |
Fluoxetine-induced apoptosis in hepatocellular carcinoma cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Fluoxetine; Humans; Liver Neoplasms; Matrix Metalloproteinases; Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Selective Serotonin Reuptake Inhibitors | 2013 |
Allostatic tumor-burden induces depression-associated changes in hepatoma-bearing mice.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Brain-Derived Neurotrophic Factor; Carcinoma, Hepatocellular; Cerebral Cortex; Depression; Disease Models, Animal; Fluoxetine; Gene Expression Regulation, Neoplastic; Glia Maturation Factor; Hindlimb Suspension; Hippocampus; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Motor Activity; Neoplasm Transplantation; RNA, Messenger; Superoxide Dismutase; Time Factors; Tumor Burden; Tumor Cells, Cultured | 2009 |
Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antiviral Agents; Cell Cycle; Depressive Disorder, Major; Desipramine; Down-Regulation; Fluoxetine; Gene Expression; Hepatoblastoma; Humans; Interferon-alpha; Jurkat Cells; Liver Neoplasms; Oligonucleotide Array Sequence Analysis; Receptor, Serotonin, 5-HT1A; Receptors, Glucocorticoid; Taurochenodeoxycholic Acid | 2005 |